4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000019
Director sold 1,377 shares at $30.88 ($42,522)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-08 | Sale : show line 1 in the form | −1,377 | $30.88 | $42,522 | 145,121 | D |
| Open-market sales · 1,377 sh · avg $30.88 · $42,522 | ||||||
Loading xslF345X03/wf-form4_167607058932396.xml…